• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk stratification tools in prostate cancer, where do we stand?

作者信息

Clinckaert Andries, Devos Gaëtan, Roussel Eduard, Joniau Steven

机构信息

Department of Urology, University Hospitals Leuven, Leuven, Belgium.

出版信息

Transl Androl Urol. 2021 Jan;10(1):12-18. doi: 10.21037/tau-20-1211.

DOI:10.21037/tau-20-1211
PMID:33532290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7844509/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/7844509/7f5290d3329c/tau-10-01-12-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/7844509/7f5290d3329c/tau-10-01-12-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/7844509/7f5290d3329c/tau-10-01-12-f1.jpg

相似文献

1
Risk stratification tools in prostate cancer, where do we stand?前列腺癌的风险分层工具，我们目前处于什么状况？
Transl Androl Urol. 2021 Jan;10(1):12-18. doi: 10.21037/tau-20-1211.
2
Novel concepts for risk stratification in prostate cancer.前列腺癌风险分层的新概念。
J Clin Urol. 2016 Dec;9(2 Suppl):18-23. doi: 10.1177/2051415816673502. Epub 2016 Dec 1.
3
External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer.ProCaRS列线图的外部验证及局限性前列腺癌现有风险分层工具的比较
Can Urol Assoc J. 2017 Mar-Apr;11(3-4):94-100. doi: 10.5489/cuaj.4084.
4
Defining high risk prostate cancer--where do we set the bar? A translational science approach to risk stratification.定义高危前列腺癌——我们该如何设定标准？一种风险分层的转化科学方法。
J Urol. 2006 Dec;176(6 Pt 2):S21-4; discussion S25-6. doi: 10.1016/j.juro.2006.06.078.
5
Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.改善原发性前列腺癌诊断时的临床风险分层：一项预后建模研究。
PLoS Med. 2016 Aug 2;13(8):e1002063. doi: 10.1371/journal.pmed.1002063. eCollection 2016 Aug.
6
Risk stratification of prostate cancer in the modern era.现代前列腺癌的风险分层
Curr Opin Urol. 2015 May;25(3):246-51. doi: 10.1097/MOU.0000000000000164.
7
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer.前列腺癌有利的中间风险、不利的中间风险和极高风险分层标准的统一。
BJU Int. 2017 Nov;120(5B):E87-E95. doi: 10.1111/bju.13903. Epub 2017 Jun 3.
8
Percentage of positive biopsy cores: a better risk stratification model for prostate cancer?阳性活检核心的百分比：前列腺癌更好的风险分层模型？
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1141-8. doi: 10.1016/j.ijrobp.2011.09.043. Epub 2011 Nov 16.
9
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis.高危前列腺癌的术前风险分层：一项多中心分析
Front Oncol. 2020 Mar 6;10:246. doi: 10.3389/fonc.2020.00246. eCollection 2020.
10
Use of two gene panels for prostate cancer diagnosis and patient risk stratification.使用两个基因检测板进行前列腺癌诊断和患者风险分层。
Tumour Biol. 2016 Aug;37(8):10115-22. doi: 10.1007/s13277-015-4619-0. Epub 2016 Jan 28.

引用本文的文献

1
Serum Calcium Level at Diagnosis Can Predict Lethal Prostate Cancer Relapse.诊断时的血清钙水平可预测致命性前列腺癌复发。
J Clin Med. 2024 Aug 16;13(16):4845. doi: 10.3390/jcm13164845.
2
Differential outcomes of re-stratified high-risk prostate cancer patients treated with external beam radiation therapy plus high-dose-rate brachytherapy boost.接受外照射放疗加近距离高剂量率后装治疗的重新分层高危前列腺癌患者的不同结局
J Contemp Brachytherapy. 2024 Apr;16(2):103-110. doi: 10.5114/jcb.2024.139277. Epub 2024 Apr 30.
3
Integrating Whole-Slide Imaging and MRI Data for Outcome Prediction after Prostatectomy in Localized Prostate Cancer.

本文引用的文献

1
Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe).多变量 PREDICT Prostate 工具在非转移性前列腺癌中的比较性能和外部验证：来自前列腺癌数据库瑞典（PCBaSe）的 69206 名男性的研究。
BMC Med. 2020 Jun 16;18(1):139. doi: 10.1186/s12916-020-01606-w.
2
Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators.头对头比较传统的、基于影像和生物标志物的前列腺癌风险计算器。
Eur Urol Focus. 2021 May;7(3):546-553. doi: 10.1016/j.euf.2020.05.002. Epub 2020 May 22.
3
整合全切片成像和MRI数据以预测局限性前列腺癌前列腺切除术后的结果
Radiol Imaging Cancer. 2024 May;6(3):e240095. doi: 10.1148/rycan.240095.
4
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.基于人工智能的 PTEN 缺失评估作为术后前列腺癌转移的早期预测指标：一项多中心回顾性研究。
Mod Pathol. 2023 Oct;36(10):100241. doi: 10.1016/j.modpat.2023.100241. Epub 2023 Jun 19.
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions.
高危局限性前列腺癌治疗的最新进展：局部治疗、系统治疗和生物标志物指导治疗决策。
Am Soc Clin Oncol Educ Book. 2020 May;40:1-12. doi: 10.1200/EDBK_279459.
4
Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.开发并内部验证一种基于网络的工具，以纵向预测放疗、手术或观察后患者的性功能、尿控和肠控情况。
Eur Urol. 2020 Aug;78(2):248-255. doi: 10.1016/j.eururo.2020.02.007. Epub 2020 Feb 22.
5
Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.局部前列腺癌主动监测、手术、近距离放疗或外照射放疗联合或不联合雄激素剥夺治疗 5 年的患者报告结局。
JAMA. 2020 Jan 14;323(2):149-163. doi: 10.1001/jama.2019.20675.
6
Artificial Intelligence and Surgical Decision-making.人工智能与手术决策。
JAMA Surg. 2020 Feb 1;155(2):148-158. doi: 10.1001/jamasurg.2019.4917.
7
How to Read Articles That Use Machine Learning: Users' Guides to the Medical Literature.如何阅读使用机器学习的文章：医学文献的用户指南。
JAMA. 2019 Nov 12;322(18):1806-1816. doi: 10.1001/jama.2019.16489.
8
Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study.不同预处理风险分层工具预测前列腺癌死亡：全国队列研究中的头对头比较。
Eur Urol. 2020 Feb;77(2):180-188. doi: 10.1016/j.eururo.2019.09.027. Epub 2019 Oct 9.
9
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review.集中治疗泌尿生殖系统恶性肿瘤于高容量提供者的影响：系统评价。
Eur Urol Oncol. 2019 May;2(3):265-273. doi: 10.1016/j.euo.2018.10.006. Epub 2018 Nov 5.
10
Reporting of artificial intelligence prediction models.人工智能预测模型的报告。
Lancet. 2019 Apr 20;393(10181):1577-1579. doi: 10.1016/S0140-6736(19)30037-6.